Patients with systemic or local inflammatory conditions were excluded by 88% of trials
Side-effect profile (BPC 157 peptide side effects + TB-500): generally mild and short-lived in reports headaches, nausea, transient blood-pressure changes, injection-site irritation
GHK-Cu has well-documented topical bioavailability and is the basis of many cosmetic serums
Dsip and Tirzepatide work through different pathways, targeting both metabolic improvement and tissue-level healing simultaneously
Here, its framed honestly: evidence-informed, monitored, and used with respect for the rest of your physiology
This is the first threshold of enhancement, he said